Key result
UMIPIC multidisciplinary care is linked to ~52% lower 1-year heart failure readmissions vs. standard care.
Why the study?
Patients with heart failure and cardiorenal syndrome face frequent hospitalizations and high mortality due to advanced age, comorbidities, and treatment challenges. The effectiveness of the multidisciplinary UMIPIC care program in mitigating these risks for this specific subgroup had not yet been explored.
Does the multidisciplinary UMIPIC care program reduce hospital readmissions and all-cause mortality at one year compared to standard care in elderly patients discharged after decompensated heart failure with cardiorenal syndrome types 2 and 4?
Cohort (n=3,255)
Yes
Does the multidisciplinary UMIPIC care program reduce hospital readmissions and all-cause mortality at one year compared to standard care in elderly patients discharged after decompensated heart failure with cardiorenal syndrome types 2 and 4?
In elderly patients with heart failure and cardiorenal syndrome types 2 and 4, a structured multidisciplinary internist- and nurse-led follow-up program (UMIPIC) is associated with significantly lower 1-year hospital readmissions and all-cause mortality compared to standard care.
Answers are grounded in this paper and cite their sources.
Supports multidisciplinary HF care in cardiorenal syndrome; leaves open confirmation by randomized trials before practice change.
Background: Individuals suffering from heart failure (HF) and cardiorenal syndrome (CRS) represent a special group of patients considering their age, multiple health issues, and treatment challenges. These factors make them more susceptible to frequent hospital stays and a higher mortality rate. UMIPIC is a multidisciplinary care model program for patients with heart failure follow up provided by internists and nurses who are experts in this entity. Our study delved into the effectiveness of this specialized care program (UMIPIC) in mitigating these risks for HF and CRS patients. Methods: We analyzed the medical records of 3255 patients diagnosed with HF and CRS types 2 and 4, sourced from the RICA registry. These patients were divided into two distinct groups: those enrolled in the UMIPIC program (1205 patients) and those under standard care (2050 patients). Using propensity score matching, we ensured that both groups were comparable. The study focused on tracking hospital admissions and mortality rates for one year after an HF-related hospital stay. Results: Patients in the UMIPIC group experienced fewer hospital readmissions due to HF compared to their counterparts (20% vs. 32%; Hazard Ratio [HR] = 0.48; 95% Confidence Interval [95% CI]: 0.40–0.57; p < 0.001). They also showed a lower mortality rate (24% vs. 36%; HR = 0.64; 95% CI: 0.54–0.75; p < 0.001). Furthermore, the UMIPIC group had fewer total hospital admissions (36% vs. 47%; HR = 0.58; 95% CI: 0.51–0.66; p < 0.001). Conclusions: The UMIPIC program, centered on holistic and ongoing care, effectively reduces both hospital admissions and mortality rates for HF and CRS patients after a one-year follow-up period.
No takes yet. Share an insight, caveat, or question.
Méndez‐Bailón et al. (2023) conducted a cohort in Heart failure and cardiorenal syndrome types 2 and 4 (n=3,255). UMIPIC multidisciplinary heart failure care program vs. Standard care (conventional follow-up by internists in the RICA registry) was evaluated on Hospital readmissions due to heart failure at 1 year (HR 0.48, 95% CI 0.40-0.57, p=<0.001). Enrolment in the UMIPIC multidisciplinary care program reduced 1-year heart failure hospital readmissions compared to standard care.
Synapse has enriched 10 related papers. Consider them for comparative context: